Embecta to buy Owen Mumford for up to £150M

Embecta to buy Owen Mumford for up to £150M
Diabetes device maker Embecta exploring sale - FT
515.8MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US29082K1051
CUSIP
29082K105
Sector
Healthcare
Industry
Medical Instruments & Supplies
Fiscal Year End
September
IPO date
-
Updated At
-
PE Ratio
3.88
PEG Ratio
-
Book Value
-10.35
Dividend Share
0.6
Dividend Yield
6.89%
Earnings Share
2.36
Wall Street Target Price
15.00
EPS Estimate Current Year
2.82
EPS Estimate Next Year
2.88
EPS Estimate Current Quarter
0.67
EPS Estimate Next Quarter
0.6675
Most Recent Quarter
-
Revenue TTM
1,079,699,968
Gross Profit TTM
681,900,032
EBITDA
366,700,000
Profit Margin
12.92%
Return On Assets TTM
18.36%
Return On Equity TTM
0.00%
Revenue Per Share TTM
18.45
Qtly Revenue Growth YOY
-0.30%
Diluted Eps TTM
2.36
Qtly Earnings Growth YOY
82.70%
Trailing PE
3.88
Forward PE
0
Price Sales TTM
0.5019
Price Book MRQ
2.6134
Enterprise Value Revenue
1
Enterprise Value EBITDA
5
186.80
3.50%300.68
1.08%106.59
1.05%44.79
0.72%149.31
0.11%185.00
0.00%205.02
-3.98%210.00
-1.98%74.09
-0.83%457.50
-0.11%